Cost-Effectiveness of Vaccination with the 20-Valent Pneumococcal Conjugate Vaccine in the Italian Adult Population

The availability of a new 20-valent pneumococcal conjugate vaccine (PCV) makes it appropriate to assess its cost-effectiveness. This was evaluated by adopting the Italian National Health Service perspective, using a cost consequences Markovian model. The expected effects of vaccination with 20-valen...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Barbara Polistena, Giancarlo Icardi, Andrea Orsi, Federico Spandonaro, Roberto Di Virgilio, Daniela d’Angela
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2022-11-01
Colecção:	Vaccines
Assuntos:	vaccines immunization cost consequences cost-effectiveness cost-utilities
Acesso em linha:	https://www.mdpi.com/2076-393X/10/12/2032
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!